Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion

被引:216
作者
Zhu, JF [1 ]
Guo, LY [1 ]
Watson, CJ [1 ]
Hu-Li, J [1 ]
Paul, WE [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.166.12.7276
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-4 plays a critical role in the differentiation of TCR-stimulated naive CD4 T cells to the Th2 phenotype. In response to IL-4, the IL-4R activates a set of phosphotyrosine binding domain-containing proteins, including insulin receptor substrate 1/2, Shc, and IL-4R interacting protein, as well as Stat6. Stat6 has been shown to be required for Th2 differentiation. To determine the roles of the phosphotyrosine binding adaptors in Th2 differentiation, we prepared a retrovirus containing a mutant of the human (h)IL-4R alpha -chain, Y497F, which is unable to recruit these adaptors. The mutant hIL-4R alpha, as well as the wild-type (WT) hIL-4R alpha, was introduced into naive CD4 T cells. Upon hIL-4 stimulation, Y497F worked as well as the WT hIL-4R alpha in driving Th2 differentiation, as measured by Gata3 up-regulation and IL-4 production. Furthermore, IL-4-driven cell expansion was also normal in the cells infected with Y497F, although cells infected with Y497F were not capable of phosphorylating insulin receptor substrate 2. These results suggest that the signal pathway mediated by Y497 is dispensable for both IL-4-driven Th2 differentiation and cell expansion. Both WT and Y497F hIL-4R alpha lose the ability to drive Th2 differentiation and cell expansion in Stat6-knockout CD4 T cells. A constitutively activated form of Stat6 introduced into CD4 T cells resulted in both Th2 differentiation and enhanced cell expansion. Thus, activated Stat6 is necessary and sufficient to mediate both IL-4-driven Th2 differentiation and cell expansion in CD4 T cells.
引用
收藏
页码:7276 / 7281
页数:6
相关论文
共 43 条
[1]   T cell differentiation: a mechanistic view [J].
Avni, O ;
Rao, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (06) :654-659
[2]  
Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO
[3]  
2-I
[4]   p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells [J].
Carpino, N ;
Wisniewski, D ;
Strife, A ;
Marshak, D ;
Kobayashi, R ;
Stillman, B ;
Clarkson, B .
CELL, 1997, 88 (02) :197-204
[5]   Jak1 expression is required for mediating interleukin-4 induced tyrosine phosphorylation of insulin receptor substrate and state signaling molecules [J].
Chen, XH ;
Patel, BKR ;
Wang, LM ;
Frankel, M ;
Ellmore, N ;
Flavell, RA ;
LaRochelle, WJ ;
Pierce, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6556-6560
[6]   A gain-of-function mutation in STAT6 [J].
Daniel, C ;
Salvekar, A ;
Schindler, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14255-14259
[7]   HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B [J].
DEFRANCE, T ;
AUBRY, JP ;
ROUSSET, F ;
VANBERVLIET, B ;
BONNEFOY, JY ;
ARAI, N ;
TAKEBE, Y ;
YOKOTA, T ;
LEE, F ;
ARAI, K ;
DEVRIES, J ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1459-1467
[8]   T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6 [J].
Dent, AL ;
Hu-Li, J ;
Paul, WE ;
Staudt, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13823-13828
[9]   AN INTERLEUKIN-4-INDUCED TRANSCRIPTION FACTOR - IL-4 STAT [J].
HOU, JZ ;
SCHINDLER, U ;
HENZEL, WJ ;
HO, TC ;
BRASSEUR, M ;
MCKNIGHT, SL .
SCIENCE, 1994, 265 (5179) :1701-1706
[10]   Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile [J].
Jankovic, D ;
Kullberg, MC ;
Noben-Trauth, N ;
Caspar, P ;
Paul, WE ;
Sher, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3047-3055